Pulmonary arterial hypertension induced by dasatinib: positive reintroduction with nilotinib

被引：0
|
作者：
Philibert, L. [1 ]
Cazorla, C. [1 ]
Peyriere, H. [1 ]
Mikulski, M. [1 ]
Guillemin, V. [1 ]
Pinzani-Harter, V. [1 ]
Hillaire-Buys, D. [1 ]
机构：
[1] CRLC Val dAurelle, Montpellier, France
来源：
FUNDAMENTAL & CLINICAL PHARMACOLOGY | 2011年 / 25卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
476
引用
收藏
页码：95 / 95
页数：1
相关论文
共 50 条
  • [31] Dasatinib [Sprycel] may increase the risk of pulmonary arterial hypertension (PAH),
    Reactions Weekly, 2011, 1374 (1) : 2 - 2
  • [32] Long Term Outcomes Of Pulmonary Arterial Hypertension In Patients Treated With Dasatinib
    Weatherald, J.
    Chaumais, M. -C.
    Savale, L.
    Jais, X.
    Seferian, A.
    Sitbon, O.
    Simonneau, G.
    Guignabert, C.
    Humbert, M.
    Montani, D.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2017, 195
  • [33] Pulmonary Arterial Hypertension Worsened by Bosutinib in Patient With Previous Dasatinib Treatment
    Parthvi, Rukma
    Gibbons, William
    AMERICAN JOURNAL OF THERAPEUTICS, 2021, 28 (06) : E704 - E706
  • [34] Dasatinib-Induced Pulmonary Arterial Hypertension in Chronic Myeloid Leukaemia: A Case Report and Literature Review
    Krishnan, Sathish
    Adigopula, Sashi
    RESPIROLOGY CASE REPORTS, 2025, 13 (03):
  • [35] Long-Term Assessment of Dasatinib-Induced Pulmonary Arterial Hypertension in Chronic Myeloid Leukemia
    Kong, Jee Hyun
    Jeon, Young-Woo
    Lee, Sung-Eun
    Choi, Soo Young
    Kim, Soo-Hyun
    Oh, Yun Jeong
    Park, Jin-Eok
    Jeon, Hye-Rim
    Jang, Eun-Jung
    Oh, Suk Joong
    Kim, Dong-Wook
    BLOOD, 2014, 124 (21)
  • [36] Real-Life Data and a Single Center Experience on Dasatinib-Induced Pulmonary Arterial Hypertension in Patients with Philadelphia Chromosome-Positive Leukemias
    Yurttas, Nurgul Ozgur
    Sadri, Sevil
    Keskin, Dilek
    Berk, Selin
    Oztunali, Isil Erdogan
    Yalniz, Fevzi Firat
    Salihoglu, Ayse
    Eskazan, Ahmet Emre
    Ar, M. Cem
    Aydin, Seniz Ongoren
    Baslar, Zafer
    Aydin, Yildiz
    Soysal, Teoman
    BLOOD, 2015, 126 (23)
  • [37] Reversible dasatinib-induced pulmonary arterial hypertension and right ventricle failure in a previously allografted CML patient
    D Mattei
    M Feola
    F Orzan
    N Mordini
    D Rapezzi
    A Gallamini
    Bone Marrow Transplantation, 2009, 43 : 967 - 968
  • [38] Reversible dasatinib-related pulmonary arterial hypertension diagnosed by noninvasive echocardiography
    Wang, Hui-Ching
    Lee, Chee-Siong
    Liu, Ta-Chih
    KAOHSIUNG JOURNAL OF MEDICAL SCIENCES, 2015, 31 (03): : 165 - 166
  • [39] In vitro and in vivo evaluation of dasatinib and imatinib on physiological parameters of pulmonary arterial hypertension
    Bethany Baumgart
    Mausumee Guha
    James Hennan
    Julia Li
    Jochen Woicke
    Damir Simic
    Michael Graziano
    Nicola Wallis
    Thomas Sanderson
    Roderick Todd Bunch
    Cancer Chemotherapy and Pharmacology, 2017, 79 : 711 - 723
  • [40] Reversible dasatinib-induced pulmonary arterial hypertension and right ventricle failure in a previously allografted CML patient
    Mattei, D.
    Feola, M.
    Orzan, F.
    Mordini, N.
    Rapezzi, D.
    Gallamini, A.
    BONE MARROW TRANSPLANTATION, 2009, 43 (12) : 967 - 968
12345